Medicenna Therapeutics (TSX:MDNA) OCF Margin %: 0.00% (As of Dec. 2025)


TSX:MDNA Medicenna Therapeutics Corp TSX:MDNA
26 GF Score
Price C$0.41
! 1 Warning Sign
View Full Analysis

What is Medicenna Therapeutics OCF Margin %?

Medicenna Therapeutics TSX:MDNA +1.23% 26 OCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates TSX:MDNA with a GF Score™ of 26/100. The stock has 1 warning sign investors should review. Among 959 Biotechnology companies, Medicenna Therapeutics ranks worse than 104275.18% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Medicenna Therapeutics's Cash Flow from Operations for the three months ended in Dec. 2025 was C$-4.97 Mil. Medicenna Therapeutics's Revenue for the three months ended in Dec. 2025 was C$0.00 Mil. Therefore, Medicenna Therapeutics's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Medicenna Therapeutics's current OCF Yield % is -51.42%.

The historical rank and industry rank for Medicenna Therapeutics's OCF Margin % or its related term are showing as below:


TSX:MDNA's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

Medicenna Therapeutics OCF Margin % Related Terms

Medicenna Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Medicenna Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicenna Therapeutics OCF Margin % Chart

Medicenna Therapeutics Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Medicenna Therapeutics Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSX:MDNA
26GF Score
Medicenna Therapeutics Corp TSX:MDNA
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicenna Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Medicenna Therapeutics's OCF Margin for the fiscal year that ended in Mar. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=-16.492/0
= %

Medicenna Therapeutics's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-4.965/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Medicenna Therapeutics (TSX:MDNA) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Medicenna Therapeutics and its competitors. According to the industry distribution chart, Medicenna Therapeutics ranks #999999 out of 959 companies in the Biotechnology industry.
Is Medicenna Therapeutics' OCF Margin % too high?
Medicenna Therapeutics' current OCF Margin % is 0.00%. Based on the distribution chart, Medicenna Therapeutics ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Medicenna Therapeutics has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Medicenna Therapeutics' OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Medicenna Therapeutics ranks #999999 out of 959 companies for OCF Margin %. This places Medicenna Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Medicenna Therapeutics and its competitors. Medicenna Therapeutics's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicenna Therapeutics stock overvalued right now?
Medicenna Therapeutics (TSX:MDNA) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Medicenna Therapeutics' overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Medicenna Therapeutics (TSX:MDNA), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medicenna Therapeutics Business Description

Other Exchanges MDNAF:USA
Address 2 Bloor Street West, Suite 903, Toronto, ON, CAN, M4W 3E2
Medicenna Therapeutics Corp is a Canada-based immuno-oncology company. Its principal business activity is the development and commercialization of IL-2, IL-4, and IL-13 Superkines and Empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. Its pipeline candidates include MDNA11 for Cancer immunotherapies, MDNA55 is a Molecular Trojan Horse, and BiSKITs represent a novel platform comprised of Bifunctional SuperKine ImmunoTherapies.
26GF Score

Get the complete analysis for TSX:MDNA

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.41
Price